Spelling suggestions: "subject:"hepatocytes"" "subject:"hépatocytes""
1 |
The role of cholesteryl ester in the assembly and secretion of apolipoprotein B100 containing lipoproteins by the liverLawrence, Scott Paul January 2001 (has links)
No description available.
|
2 |
Aspects of phosphatidylethanolamine metabolism during the initial phase of rat liver regenerationPhillips, Patrick January 1994 (has links)
No description available.
|
3 |
Control of hepatic fatty acid oxidationSpurway, Tracy Deborah January 1995 (has links)
No description available.
|
4 |
Intermediate filaments in hepatocytesAlexander, C. M. January 1984 (has links)
No description available.
|
5 |
The development of a bioartificial liver support systemBratch, Kaljit Kaur January 1999 (has links)
No description available.
|
6 |
Effects of conditional expression of hepatitis C virus proteins on non-transformed human hepatocyte line HH4 cells /Tang, Weiliang. January 2006 (has links)
Thesis (Ph. D.)--University of Washington, 2006. / Vita. Includes bibliographical references (leaves 100-129).
|
7 |
Asialofetuin-coated PLGA Nanoparticles for Targeting HepatocytesKharaud, Gagandeep Unknown Date
No description available.
|
8 |
Dissection of the Fas mediated apoptosis pathwayJones, Richard A. January 2000 (has links)
No description available.
|
9 |
Cryopreservation of hepatocyte monolayers : a potential in vitro model system for toxicity testingMcKay, Gillian Claire January 2001 (has links)
No description available.
|
10 |
Asialofetuin-coated PLGA Nanoparticles for Targeting HepatocytesKharaud, Gagandeep 11 1900 (has links)
The purpose of this project was to formulate, modify and evaluate nanoparticles for targeting asialoglycoprotein receptor found in large numbers exclusively on hepatocyte surfaces. Our goal is to increase the efficacy, reduce the side effects and the cost of the hydrophilic drugs administered to cure diseases like hepatitis C virus. Selective drug delivery into targeted cells using nanoparticles is one effective approach to enhance activity and avoid systemic side effects. Here we describe our effort towards the development of specially engineered poly(D,L-lactic-co-glycolic acid) nanoparticles using double emulsion method and surface coat them with asialofetuin for targeted delivery into hepatocytes. Bovine Serum Albumin-coated nanoparticles were prepared as a negative control. Furthermore, covalently conjugated protein on nanoparticle was labeled with rhodamine and was used for cell-based studies. Results from these studies indicated that asialofetuin conjugated with nanoparticles showed enhanced and selective uptake by hepatocytes compared to nanoparticles conjugated with Bovine Serum Albumin. / Pharmaceutical Sciences
|
Page generated in 0.0454 seconds